Investment Summary

BioLife Solutions Invests In PanTHERA CryoSolutions

On December 1, 2020, BioLife Solutions invested in life science company PanTHERA CryoSolutions

Investment Highlights
  • This is BioLife Solutions’ 2nd transaction in the Life Science sector.
  • This is BioLife Solutions’ 1st transaction in Canada.
  • This is BioLife Solutions’ 1st transaction in Alberta.

Investment Summary

Date 2020-12-01
Target PanTHERA CryoSolutions
Sector Life Science
Investor(s) BioLife Solutions
Deal Type Stake Purchase

Target

PanTHERA CryoSolutions

Edmonton, Alberta, Canada
PanTHERA CryoSolutions is a developer of novel cryopreservation solutions based on proprietary Ice Recrystallization Inhibitor technology. PanTHERA CryoSolutions is based in Edmonton, Alberta.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

BioLife Solutions

Bothell, Washington, United States

Category Company
Founded 1987
Sector Life Science
Employees159
Revenue 82M USD (2024)
DESCRIPTION

BioLife Solutions is a developer, manufacturer and supplier of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media for cells and tissues. Our proprietary HypoThermosol® and CryoStor® platform of solutions are highly valued in the regenerative medicine, biobanking and drug discovery markets. Our biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death; offering commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function. BioLife Solutions was founded in 1987 and is based in Bothell, Washington.


DEAL STATS #
Overall 5 of 7
Sector: Life Science M&A 2 of 3
Type: Stake Purchase M&A Deals 2 of 2
State: Alberta M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2020 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-09-21 SciSafe

Cranbury, New Jersey, United States

SciSafe is a provider of biological materials storage to the cell and gene therapy and pharmaceutical industries. SciSafe was established in 2010 and is based in Cranbury, New Jersey.

Buy $39M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-03-22 Stirling Ultracold

Athens, Ohio, United States

Stirling Ultracold is a manufacturer of ultra-low temperature ("ULT") mechanical freezers. Stirling Ultracold also produces portable ULT solution available for remote clinical trials and biologic drug delivery. Stirling Ultracold was founded in 2009 and is based in Athens, Ohio.

Buy -